How should we approach thyroidal incidentalomas detected on FDG-PET/ CT imaging?

Aim: Thyroidal incidentalomas (Tis) detected by F-18 fluorodeoxyglucose positron emission tomography/computed tomography (F-18FDG PET/CT) may be associated with three different causes that include metastasis of another malignancy, primary thyroid gland malignancies and lastly benign thyroidal nodules, all require different clinical approaches. For appropriate treatment, quick characterization of the Ti is important, preferably with a lesser invasive method. Our aim was to determine whether the characterization of TIs can be performed with FDG-PET/CT, due to contribute faster diagnosis, and initiation of the therapy. Material and Methods: Forty-four patients with detected TIs in FDG-PET/CT were included in the study. The relationship between metabolically/morphological parameters and pathology results were evaluated statistically. If two subsequent cytology were negative, nodule accepted as benign. If cytology result was suspected or malignant, histopathological confirmation was made. For these patients, histopathological results were accepted as definite diagnosis. Results: Malignant thyroidal pathologies were detected in 29.5% of patients. We could not find any significant relationship between age, nodule size and SUVmax value and pathology results. According to ROC analysis, there were not any cut-off value for nodule size and SUVmax. Similar results were also obtained for papillary carcinoma as a special subgroup. Conclusion: Characterisation of TIs could not be performed by using age, nodule size and SUVmax. Therefore, TIs which detected by FDG-PET/CT should be examined pathologically due to high risk of malignancy.

[1]  M. Sathekge,et al.  Higher preablative serum thyroid-stimulating hormone level predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma , 2017, Nuclear medicine communications.

[2]  M. Adaş,et al.  Incidental thyroid lesions on FDG-PET/CT: a prevalence study and proposition of management. , 2015, Minerva endocrinologica.

[3]  I. Žagar,et al.  Thyroid lesions incidentally detected by 18F-FDG PET-CT — a two centre retrospective study , 2015, Radiology and oncology.

[4]  J. Park,et al.  Risk of Malignancy in Thyroid Incidentalomas Identified by Fluorodeoxyglucose-Positron Emission Tomography , 2015, Endocrinology and metabolism.

[5]  O. Yaylalı,et al.  Evaluation of focal thyroid lesions incidentally detected in fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography images. , 2014, Indian journal of cancer.

[6]  Bo Hyun Kim,et al.  Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma , 2013, Nuclear medicine communications.

[7]  Seong-Jang Kim,et al.  Thyroid Incidentalomas on FDG PET/CT in Patients with Non-Thyroid Cancer - a Large Retrospective Monocentric Study , 2013, Oncology Research and Treatment.

[8]  A. Piccardo,et al.  Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. , 2012, The Journal of clinical endocrinology and metabolism.

[9]  L. Hegedüs,et al.  Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review. , 2012, Thyroid : official journal of the American Thyroid Association.

[10]  I. Lim,et al.  Characteristics of thyroid incidentalomas detected by pre-treatment [18F]FDG PET or PET/CT in patients with cervical cancer , 2012, Journal of gynecologic oncology.

[11]  S. Kim,et al.  Characteristics of Primary Papillary Thyroid Carcinoma with False-Negative Findings on Initial 18F-FDG PET/CT , 2011, Annals of Surgical Oncology.

[12]  Bo Hyun Kim,et al.  Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation , 2010, Annals of nuclear medicine.

[13]  A. Shaha,et al.  Management of thyroid nodules and surgery for differentiated thyroid cancer. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[14]  S. Nishizawa,et al.  High incidence of thyroid cancer in focal thyroid incidentaloma detected by 18F-fluorodeoxyglucose [corrected] positron emission tomography in relatively young healthy subjects: results of 3-year follow-up. , 2010, Endocrine journal.

[15]  L. Pagano,et al.  Thyroid Incidentaloma identified by 18F-Fluorodeoxyglucose Positron Emission Tomography with CT (FDG-PET/CT): clinical relevance , 2010 .

[16]  Thomas Beyer,et al.  Dual-modality PET/CT instrumentation-today and tomorrow. , 2010, European journal of radiology.

[17]  R. Cardarelli,et al.  Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography , 2009, Nuclear medicine communications.

[18]  H. Gharib,et al.  Epidemiology of thyroid nodules. , 2008, Best practice & research. Clinical endocrinology & metabolism.

[19]  Jin Young Kwak,et al.  US-guided fine-needle aspiration of thyroid nodules: indications, techniques, results. , 2008, Radiographics : a review publication of the Radiological Society of North America, Inc.

[20]  Jeong Hyun Lee,et al.  Focal uptake of 18F‐fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers , 2007 .

[21]  Tae Yong Kim,et al.  18F‐Fluorodeoxyglucose Uptake in Thyroid from Positron Emission Tomogram (PET) for Evaluation in Cancer Patients: High Prevalence of Malignancy in Thyroid PET Incidentaloma , 2005, The Laryngoscope.

[22]  L. Hegedüs,et al.  Clinical practice. The thyroid nodule. , 2004, The New England journal of medicine.

[23]  Seung-Yong Jeong,et al.  Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. , 2003, The Journal of clinical endocrinology and metabolism.

[24]  H. Stettner,et al.  Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. , 2003, Surgery.

[25]  G Ziemer,et al.  Value of positron emission tomography for lung cancer staging. , 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[26]  J. Palazzo,et al.  Pathologic features of Hashimoto's-associated papillary thyroid carcinomas. , 2001, Human pathology.

[27]  H. Gharib,et al.  Thyroid Incidentalomas: Management Approaches to Nonpalpable Nodules Discovered Incidentally on Thyroid Imaging , 1997, Annals of Internal Medicine.

[28]  L. Woolner,et al.  Gross and microscopic findings in clinically normal thyroid glands. , 1955, The Journal of clinical endocrinology and metabolism.